FDA approves Lannett's ANDA for Phentermine Resin Extended-Release Capsules
Links shared publicly online about this topic.
- 111total visits
FDA approves Lannett's ANDA for Phentermine Resin Extended-Release Capsules
Lannett Company, Inc. today announced the U.S. Food and Drug Administration (FDA) approved its Abbreviated New Drug Application (ANDA) for Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg, representing the fourth product approval the company has received in the last five weeks.
View full resource at news-medical.net
Tags: Obesity, Appetite Suppressant, Diet and Nutrition, Drug, FDA, Fastin, News
Most Recently Shared on July 29, 2011 at 2:47 pm By:
Obesity News: FDA approves Lannett's ANDA for Phentermine Resin Extended-Release Capsules: Lannett Company, In... http://twurl.nl/072zka
Lannett Receives FDA Approval for Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg - Drugs.com MedNews
drugs.com — “Jul 29, 2011 - Lannett Company, Inc. (NYSE AMEX LCI) today announced the U.S. Food and Drug Administration (FDA) approved its Abbreviated New Drug Application (” View full resource at drugs.com
Most Recently Shared on August 1, 2011 at 2:05 pm By:
Drugs and Devices OW OW Health
Lannett Receives FDA Approval for Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg: PHILADELPH... http://bit.ly/oF5Zbm #drug
Advertisement
